Please login to the form below
Actavis
The Top Pharma List rankings are compiled from GlobalData's
pharmaceutical revenue figures, which are based on prescription medicine
sales, including generics drugs.
Teva wins FDA OK for crucial migraine drug
order to pay down a very high level of debt stemming from its $39bn acquisition of Allergan’s generics business Actavis in 2015.
Axovant poaches Allergan’s and Teva’s chief medical and science officers
Most recently, Corcoran served as chief medical officer at Allergan and before that he was Actavis’ chief medical officer.
Morning brief: Roche raises outlook for 2018, ASCO abstracts revealed and more
The $64bn sum makes the deal the biggest pharma M&A transaction since Actavis bought Allergan in 2015 for $70.5bn.
Shire warms to Takeda’s latest offer, extending deadline
Analysts suggest however that negative sentiment could still scupper a deal that is by far the largest ever undertaken by the company - and the biggest in pharma since the $70bn
Shire rebuffs Takeda bids, as Allergan bows out
Allergan - also headquartered in Ireland - is no stranger to the M&A game having been bulked up by serial acquisitions in recent years, including a $66bn merger with Actavis in 2014
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Featured jobs
- Account Executive/ Senior Account Executive
-
competitive Salary Offfered
- Senior Account Executive with progression to Account Manager, Me...
-
Excellent package
- Business Development Director – Health Education
-
excellent commission
-
Account Manager
-
Negotiable
-
Senior Account Manager
-
Competitive Salary Offered
-
Account Manager / Account Director
-
Competative
-
Medical Writer
-
Salary TBC
-
Systematic Reviewer - Oxford
-
Negotiable
-
Experienced Medical Writers
-
Competitive Salary and Benefits
-
Associate Medical Director
-
Excellent PTO, bonus and 401k package
-
Associate Director
-
£75, 000-90, 000
-
Account Director
-
Competitive Salary Offered
-
Medical (Scientific) Director
-
£120, 000 benefits
Subscribe to our email news alerts
- AstraZeneca’s oncology renaissance
- New editor adds microscopic attention to detail at Porterhouse Medical
- NICE says no to rival Alnylam and Akcea amyliodsis drugs – but deal could be done
- Brexit contributes to surge in generic drug prices
- Navigating the antibiotic resistance crisis
- J&J takes on Novartis’ Cosentyx with head-to-head psoriasis trial
Latest intelligence
- AstraZeneca’s oncology renaissance
- Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
- Navigating the antibiotic resistance crisis
- Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
- Combined immunotherapies – potential and pitfalls
- ‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Quick links
Infographics
